Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pancreatic Carcinoma Stage III”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT05040360
What this trial is testing

Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors

Who this might be right for
Metastatic Malignant Neoplasm in the LiverPancreatic Neuroendocrine TumorStage I Pancreatic Neuroendocrine Tumor AJCC v8+2 more
SWOG Cancer Research Network 141
Early research (Phase 1)Study completedNCT00033241
What this trial is testing

Erlotinib Combined With Gemcitabine in Treating Patients With Newly Diagnosed Locally Advanced or Metastatic Pancreatic Cancer or Other Solid Tumors

Who this might be right for
Pancreatic CancerUnspecified Adult Solid Tumor, Protocol Specific
OSI Pharmaceuticals
Early research (Phase 1)Ended earlyNCT00310050
What this trial is testing

Pemetrexed, Gemcitabine, and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Wake Forest University Health Sciences 4
Early research (Phase 1)Study completedNCT02333188
What this trial is testing

Genetic Analysis-Guided Dosing of FOLFIRABRAX in Treating Patients With Advanced Gastrointestinal Cancer

Who this might be right for
Adenocarcinoma of Unknown PrimaryAdult CholangiocarcinomaGallbladder Carcinoma+14 more
University of Chicago 50
Testing effectiveness (Phase 2)Study completedNCT00049348
What this trial is testing

Chemotherapy and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Eastern Cooperative Oncology Group
Not applicableStudy completedNCT04449679
What this trial is testing

Real-Time Monitoring of Chemotherapy Side-Effects in Patients With Gastrointestinal Cancers, RT-CAMSS Study

Who this might be right for
Clinical Stage 0 Esophageal Adenocarcinoma AJCC v8Clinical Stage 0 Esophageal Squamous Cell Carcinoma AJCC v8Clinical Stage 0 Gastric Cancer AJCC v8+83 more
Thomas Jefferson University 34
Testing effectiveness (Phase 2)Study completedNCT01433263
What this trial is testing

Clinical Study of BYM338 for the Treatment of Unintentional Weight Loss in Patients With Cancer of the Lung or the Pancreas

Who this might be right for
Cachexia
Novartis Pharmaceuticals 57
Testing effectiveness (Phase 2)Study completedNCT00005832
What this trial is testing

S9924 R115777 in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
SWOG Cancer Research Network 58
Testing effectiveness (Phase 2)Study completedNCT00002773
What this trial is testing

Vaccine Therapy, Chemotherapy, and GM-CSF in Treating Patients With Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
St. Vincent Medical Center - Los Angeles
Not applicableStudy completedNCT00253383
What this trial is testing

Early Intervention vs. Standard Palliative Care in Improving End-of-Life Care in Advanced Cancer Patients

Who this might be right for
Cancer
Dartmouth-Hitchcock Medical Center 329
Testing effectiveness (Phase 2)Ended earlyNCT01897454
What this trial is testing

Gemcitabine Hydrochloride, and Radiation Therapy in Patients With Borderline Resectable Pancreatic Cancer

Who this might be right for
Pancreatic AdenocarcinomaStage IIA Pancreatic CancerStage IIB Pancreatic Cancer+1 more
Albert Einstein College of Medicine 23
Testing effectiveness (Phase 2)Study completedNCT00004861
What this trial is testing

Gemcitabine With or Without CI-994 in Treating Patients With Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Pfizer
Not applicableStudy completedNCT01327794
What this trial is testing

Relationship Between Vitamin D Biomarkers and Survival in Blood Samples From Patients With Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Alliance for Clinical Trials in Oncology 265
Early research (Phase 1)Study completedNCT02451553
What this trial is testing

Afatinib Dimaleate and Capecitabine in Treating Patients With Advanced Refractory Solid Tumors, Pancreatic Cancer or Biliary Cancer

Who this might be right for
Advanced Malignant Solid NeoplasmBile Duct CarcinomaRecurrent Malignant Solid Neoplasm+4 more
University of Washington 41
Testing effectiveness (Phase 2)Study completedNCT01525082
What this trial is testing

Capecitabine, Temozolomide, and Bevacizumab for Metastatic or Unresectable Pancreatic Neuroendocrine Tumors

Who this might be right for
GastrinomaGlucagonomaInsulinoma+6 more
Shaheen Shagufta 20
Early research (Phase 1)Ended earlyNCT03878524
What this trial is testing

Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME Trial

Who this might be right for
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveAnatomic Stage IV Breast Cancer AJCC v8Anemia+47 more
OHSU Knight Cancer Institute 2
Early research (Phase 1)Study completedNCT00003411
What this trial is testing

Radiation Therapy in Treating Patients With Bile Duct, Gallbladder, or Pancreatic Cancer

Who this might be right for
Extrahepatic Bile Duct CancerGallbladder CancerPancreatic Cancer
University of Pittsburgh
Early research (Phase 1)Ended earlyNCT00003434
What this trial is testing

Biological Therapy in Stage I, Stage II, or Stage III Surgically Resected Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Duke University 8
Testing effectiveness (Phase 2)Study completedNCT00064051
What this trial is testing

3-AP and Gemcitabine in Treating Patients With Unresectable or Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Vion Pharmaceuticals
Testing effectiveness (Phase 2)Study completedNCT01959672
What this trial is testing

Chemotherapy, Stereotactic Body Radiation Therapy & Nelfinavir Mesylate in Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreatic AdenocarcinomaResectable Pancreatic CarcinomaStage I Pancreatic Cancer+6 more
University of Nebraska 11
Next Page